IMbark Phase Two Updated Results reported today

Global Newswire on 12-3-2018 had the headline: “Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis…

Read more